OXIGENE THE VASCULAR TARGETING COMPANY
Cancer research; research and development of biopharmaceutical products, namely, vascular targeting agents and cancer therapies; and licensing of intellectual property in the field of biopharmaceutical compounds for vascular targeting agents and cancer therapies
Cancelled · August 28, 2001 · 76306207 ·